Clinical trial
Multicentre, Double-blind Study Versus Placebo on the Impact and Safety of the Daily Administration of Extramel® 140 IU for 12 Weeks on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception, if Present, and the Impact on the Quality of Life of 70 Subjects Included, of Which 60 That Can be Evaluated
NCT01767922 is registered in ClinicalTrials.gov with Robertet SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre, Double-blind Study Versus Placebo on the Impact and Safety of the Daily Administration of Extramel® 140 IU for 12 Weeks on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception, if Present, and the Impact on the Quality of Life of 70 Subjects Included, of Which 60 That Can be Evaluated
- Lead sponsor
- Robertet SA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- September 30, 2009
- Enrollment
- 61 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.